The gefitinib dose reduction on survival outcomes in epidermal growth factor receptor mutant non-small cell lung cancer

詳細情報 詳細情報について

• CRID

  1363670320441843968

• DOI

  10.1007/s00432-014-1768-2

• ISSN

  14321335

  01715216

• Web Site

  https://link.springer.com/content/pdf/10.1007/s00432-014-1768-2.pdf

  https://link.springer.com/article/10.1007/s00432-014-1768-2/fulltext.html

  http://link.springer.com/content/pdf/10.1007/s00432-014-1768-2

• データソース種別

  • Crossref